000 01407 a2200433 4500
005 20250513153154.0
264 0 _c19981217
008 199812s 0 0 eng d
022 _a1061-186X
024 7 _a10.3109/10611869808997861
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMelgert, B N
245 0 0 _aTargeting of naproxen covalently linked to HSA to sinusoidal cell types of the liver.
_h[electronic resource]
260 _bJournal of drug targeting
_c1998
300 _a329-42 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xblood
650 0 4 _aDrug Carriers
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aKupffer Cells
_xmetabolism
650 0 4 _aLiver
_xmetabolism
650 0 4 _aLysine
_xanalogs & derivatives
650 0 4 _aMale
650 0 4 _aNaproxen
_xanalogs & derivatives
650 0 4 _aRats
650 0 4 _aRats, Wistar
650 0 4 _aSerum Albumin
_xchemistry
700 1 _aWartna, E
700 1 _aLebbe, C
700 1 _aAlbrecht, C
700 1 _aMolema, G
700 1 _aPoelstra, K
700 1 _aReichen, J
700 1 _aMeijer, D K
773 0 _tJournal of drug targeting
_gvol. 5
_gno. 5
_gp. 329-42
856 4 0 _uhttps://doi.org/10.3109/10611869808997861
_zAvailable from publisher's website
999 _c9736319
_d9736319